Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In situ measurements of the physical characteristics of Titan's environment.
Fulchignoni M, Ferri F, Angrilli F, Ball AJ, Bar-Nun A, Barucci MA, Bettanini C, Bianchini G, Borucki W, Colombatti G, Coradini M, Coustenis A, Debei S, Falkner P, Fanti G, Flamini E, Gaborit V, Grard R, Hamelin M, Harri AM, Hathi B, Jernej I, Leese MR, Lehto A, Lion Stoppato PF, López-Moreno JJ, Mäkinen T, McDonnell JA, McKay CP, Molina-Cuberos G, Neubauer FM, Pirronello V, Rodrigo R, Saggin B, Schwingenschuh K, Seiff A, Simões F, Svedhem H, Tokano T, Towner MC, Trautner R, Withers P, Zarnecki JC. Fulchignoni M, et al. Among authors: bianchini g. Nature. 2005 Dec 8;438(7069):785-91. doi: 10.1038/nature04314. Epub 2005 Nov 30. Nature. 2005. PMID: 16319827
S.A.M., the Italian Martian simulation chamber.
Galletta G, Ferri F, Fanti G, D'Alessandro M, Bertoloni G, Pavarin D, Bettanini C, Cozza P, Pretto P, Bianchini G, Debei S. Galletta G, et al. Among authors: bianchini g. Orig Life Evol Biosph. 2006 Dec;36(5-6):625-7. doi: 10.1007/s11084-006-9046-1. Orig Life Evol Biosph. 2006. PMID: 17120119
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy.
Corti C, Binboğa Kurt B, Koca B, Rahman T, Conforti F, Pala L, Bianchini G, Criscitiello C, Curigliano G, Garrido-Castro AC, Kabraji SK, Waks AG, Mittendorf EA, Tolaney SM. Corti C, et al. Among authors: bianchini g. Cancer Treat Rev. 2024 Nov 13;132:102852. doi: 10.1016/j.ctrv.2024.102852. Online ahead of print. Cancer Treat Rev. 2024. PMID: 39571402 Free article. Review.
Inhibition of phototrophic iron oxidation by nitric oxide in ferruginous environments.
Nikeleit V, Mellage A, Bianchini G, Sauter L, Buessecker S, Gotterbarm S, Schad M, Konhauser K, Zerkle AL, Sánchez-Baracaldo P, Kappler A, Bryce C. Nikeleit V, et al. Among authors: bianchini g. Nat Geosci. 2024;17(11):1169-1174. doi: 10.1038/s41561-024-01560-9. Epub 2024 Oct 4. Nat Geosci. 2024. PMID: 39526045 Free PMC article.
Development and validation of a gene expression-based Breast Cancer Purity Score.
Barreca M, Dugo M, Galbardi B, Győrffy B; NA-PHER2 consortium; NeoTRIP consortium; Valagussa P, Besozzi D, Viale G, Bianchini G, Gianni L, Callari M. Barreca M, et al. Among authors: bianchini g. NPJ Precis Oncol. 2024 Oct 24;8(1):242. doi: 10.1038/s41698-024-00730-7. NPJ Precis Oncol. 2024. PMID: 39448787 Free PMC article.
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).
Turner N, Saura C, Aftimos P, van den Tweel E, Oesterholt M, Koper N, Colleoni M, Kaczmarek E, Punie K, Song X, Armstrong A, Bianchi G, Stradella A, Ladoire S, Lim JSJ, Quenel-Tueux N, Tan TJ, Escrivá-de-Romaní S, O'Shaughnessy J; TULIP Trial Investigators. Turner N, et al. J Clin Oncol. 2024 Oct 23:JCO2400529. doi: 10.1200/JCO.24.00529. Online ahead of print. J Clin Oncol. 2024. PMID: 39442070
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.
Dugo M, Huang CS, Egle D, Bermejo B, Zamagni C, Seitz RS, Nielsen TJ, Thill M, Antón-Torres A, Russo S, Ciruelos EM, Schweitzer BL, Ross DT, Galbardi B, Greil R, Semiglazov V, Gyorffy B, Colleoni M, Kelly CM, Mariani G, Del Mastro L, Blasi O, Callari M, Pusztai L, Valagussa P, Viale G, Gianni L, Bianchini G. Dugo M, et al. Among authors: bianchini g. Clin Cancer Res. 2024 Nov 1;30(21):4900-4909. doi: 10.1158/1078-0432.CCR-24-0149. Clin Cancer Res. 2024. PMID: 39308141 Free PMC article. Clinical Trial.
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU; DESTINY-Breast12 study group. Harbeck N, et al. Among authors: bianchini g. Nat Med. 2024 Sep 13. doi: 10.1038/s41591-024-03261-7. Online ahead of print. Nat Med. 2024. PMID: 39271844
290 results